GaldermaDeliversRecord2025ResultsWithNetSalesof5.207BillionUSD,up17.7%atConstantCurrency1,andCoreEBITDA2of1.211billionUSD,Growing18.9%atConstantCurrency
===2026/3/5 16:11:22===
Net income
231
613
Total EBITDA adjustments8
93
59
VCB financing revaluation9
(28)
-
Amortization
229
246
Foreign exchange loss on financing activities
7
0
Income taxes on above items
(36)
(47)
=*=*=*=*=*=
当前为第40/55页
下一页-上一页-
=*=*=*=*=*=
返回新闻列表
返回网站首页